nOCD raises $1M in funding for OCD help app

By Laura Lovett
04:20 pm
Share

nOCD, a new app that helps users manage their obsessive compulsive disorder (OCD) just landed $1 million in seed funding from 7wire Ventures. The Chicago-based startup aims to help people living with OCD by providing cognitive behavioral therapy through the platform. The free app also connects people to support groups and others who also are living with OCD. 

Users can access educational material, Exposure Response Prevention Therapy guidance, and customizable treatment plans. The platform also tracks 56 metrics of longitudinal data and can analyze real-time treatment data to help users understand their progress. 

Founder and CEO Stephen Smith knows what it is like living with OCD all too well. In college he struggled with the condition.

“I developed nOCD to fix the broken behavioral health treatment system. After my sophomore year of college, I developed severe OCD and major depression, and like many people, it cost me tens of thousands of dollars and over 5 clinicians to access effective care,” Smith wrote in an email to MobiHealthNews. “Once I accessed care, it cost me even more money and tremendous strain to stay compliant to treatment, since 99 percent of the time I was forced to manage my condition alone. nOCD is solving all of these issues.”

The startup was founded in 2014, according to Crunchbase. However, this is the first major funding received by the company. 

“The funding will allow us to make our treatment platform more robust, enhancing the treatment ecosystem for both patients and their care team,” Smith wrote.

But, Smith said, in the next few years the company hopes to expand its reach and be able to target users at different stages of their treatment. 

“We’re focused on delivering a multi-tiered approach, that helps engage patients through a continuum of online support from one’s self, community, and even clinician,” said Smith. “By doing this, our goal is to prevent people from developing severe OCD, major depressive disorder, and substance use disorder.”

Share